stoxline Quote Chart Rank Option Currency Glossary
  
Kineta, Inc. (KA)
0.683  -0.017 (-2.4%)    07-19 14:35
Open: 0.6995
High: 0.7475
Volume: 33,698
  
Pre. Close: 0.7
Low: 0.6827
Market Cap: 8(M)
Technical analysis
2024-07-19 2:21:57 PM
Short term     
Mid term     
Targets 6-month :  0.96 1-year :  1.13
Resists First :  0.82 Second :  0.96
Pivot price 0.67
Supports First :  0.59 Second :  0.45
MAs MA(5) :  0.7 MA(20) :  0.66
MA(100) :  0.61 MA(250) :  2.02
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  57 D(3) :  60.7
RSI RSI(14): 55
52-week High :  5.38 Low :  0.33
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ KA ] has closed below upper band by 44.9%. Bollinger Bands are 44.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 83 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.74 - 0.75 0.75 - 0.75
Low: 0.68 - 0.69 0.69 - 0.69
Close: 0.69 - 0.69 0.69 - 0.7
Company Description

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

Headline News

Wed, 10 Jul 2024
Kineta (NASDAQ:KA) Trading 15.2% Higher - Defense World

Mon, 08 Jul 2024
Kineta Inc (KA) Stock: A Year of Highs and Lows - The InvestChronicle

Mon, 08 Jul 2024
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor - PR Newswire

Mon, 08 Jul 2024
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences - StockTitan

Mon, 17 Jun 2024
A look at KA’s current quarter earnings estimates - US Post News

Tue, 05 Mar 2024
symbol__ Stock Quote Price and Forecast - CNN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 12 (M)
Shares Float 7 (M)
Held by Insiders 34.9 (%)
Held by Institutions 12.5 (%)
Shares Short 117 (K)
Shares Short P.Month 87 (K)
Stock Financials
EPS -1.4
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.57
Profit Margin 0 %
Operating Margin -303.2 %
Return on Assets (ttm) -126.3 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0.42
EBITDA (p.s.) -1.28
Qtrly Earnings Growth 0 %
Operating Cash Flow -15 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -0.5
PEG Ratio 0
Price to Book value -1.24
Price to Sales 1.64
Price to Cash Flow -0.56
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2000-01-10
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android